[1] Ge L, Arul K, Ikpeze T, et al. Traumatic and Nontraumatic Spinal Cord Injuries. World Neurosurg. 2018;111:e142-e148.[2] Tafida MA, Wagatsuma Y, Ma E, et al. Descriptive epidemiology of traumatic spinal injury in Japan. J Orthop Sci. 2018;23(2): 273-276.[3] Ning GZ, Wu Q, Li YL, et al. Epidemiology of traumatic spinal cord injury in Asia: a systematic review. J Spinal Cord Med. 2012;35(4): 229-239.[4] Chen R, Liu X, Han S, et al. Current epidemiological profile and features of traumatic spinal cord injury in Heilongjiang province, Northeast China: implications for monitoring and control. Spinal Cord. 2017;55(4):399-404.[5] Sekhon LH, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila Pa 1976). 2001;26(24 Suppl):S2-12.[6] National Spinal Cord Injury Statistical Center. Spinal cord injury facts and figures at a glance. J Spinal Cord Med. 2013;36(1):1-2.[7] Mothe AJ, Tator CH. Advances in stem cell therapy for spinal cord injury. J Clin Invest. 2012;122(11):3824-3834.[8] Leal-Filho MB. Spinal cord injury: From inflammation to glial scar. Surg Neurol Int. 2011;2:112.[9] Fehlings MG, Tighe A. Spinal cord injury: the promise of translational research. Neurosurg Focus. 2008;25(5):E1.[10] 张海燕,杨朝阳,李晓光. 大鼠脊髓损伤后胶质瘢痕形成的病理学规律[J]. 中国康复理论与实践, 2011, 17(3):215-218.[11] Bracken MB. Steroids for acute spinal cord injury. Cochrane Database Syst Rev. 2012;1:CD001046.[12] Jia YF, Gao HL, Ma LJ, et al. Effect of nimodipine on rat spinal cord injury. Genet Mol Res. 2015;14(1):1269-1276.[13] Friedenstein AJ, Chailakhyan RK, Gerasimov UV. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet. 1987;20(3):263-272.[14] Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002; 418(6893):41-49.[15] Chamberlain G, Fox J, Ashton B, et al. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007;25(11):2739-2749.[16] Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.[17] Lou G, Chen Z, Zheng M, et al. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp Mol Med. 2017;49(6):e346.[18] Börger V, Bremer M, Ferrer-Tur R, et al. Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles and Their Potential as Novel Immunomodulatory Therapeutic Agents. Int J Mol Sci. 2017;18(7): E1450.[19] Aqmasheh S, Shamsasanjan K, Akbarzadehlaleh P, et al. Effects of Mesenchymal Stem Cell Derivatives on Hematopoiesis and Hematopoietic Stem Cells. Adv Pharm Bull. 2017;7(2):165-177.[20] Liang L, Li Z, Ma T, et al. Transplantation of Human Placenta-Derived Mesenchymal Stem Cells Alleviates Critical Limb Ischemia in Diabetic Nude Rats. Cell Transplant. 2017; 26(1):45-61.[21] Han ZC, Du WJ, Han ZB, et al. New insights into the heterogeneity and functional diversity of human mesenchymal stem cells. Biomed Mater Eng. 2017;28(s1):S29-S45.[22] Shende P, Subedi M. Pathophysiology, mechanisms and applications of mesenchymal stem cells for the treatment of spinal cord injury. Biomed Pharmacother. 2017;91:693-706.[23] Gu C, Li H, Wang C, et al. Bone marrow mesenchymal stem cells decrease CHOP expression and neuronal apoptosis after spinal cord injury. Neurosci Lett. 2017;636:282-289.[24] Zhukareva V, Obrocka M, Houle JD, et al. Secretion profile of human bone marrow stromal cells: donor variability and response to inflammatory stimuli. Cytokine. 2010;50(3):317-321.[25] Morita T, Sasaki M, Kataoka-Sasaki Y, et al. Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury. Neuroscience. 2016;335: 221-231.[26] Kim Y, Jo SH, Kim WH, et al. Antioxidant and anti-inflammatory effects of intravenously injected adipose derived mesenchymal stem cells in dogs with acute spinal cord injury. Stem Cell Res Ther. 2015;6:229.[27] Li J, Guo W, Xiong M, et al. Erythropoietin facilitates the recruitment of bone marrow mesenchymal stem cells to sites of spinal cord injury. Exp Ther Med. 2017;13(5):1806-1812.[28] Escalhão CCM, Ramos IP, Hochman-Mendez C, et al. Safety of Allogeneic Canine Adipose Tissue-Derived Mesenchymal Stem Cell Intraspinal Transplantation in Dogs with Chronic Spinal Cord Injury. Stem Cells Int. 2017;2017:3053759.[29] Tang L, Lu X, Zhu R, et al. Adipose-Derived Stem Cells Expressing the Neurogenin-2 Promote Functional Recovery After Spinal Cord Injury in Rat. Cell Mol Neurobiol. 2016;36(5):657-667.[30] Wang GD, Liu YX, Wang X, et al. The SDF-1/CXCR4 axis promotes recovery after spinal cord injury by mediating bone marrow-derived from mesenchymal stem cells. Oncotarget. 2017; 8(7):11629-11640.[31] 谢桂琴,徐晓静,张焕相. 基质细胞衍生因子-1α对间充质干细胞迁移的影响[J]. 江苏大学学报:医学版, 2014, 24(4):277-282.[32] Wei GJ, An G, Shi ZW, et al. Suppression of MicroRNA-383 Enhances Therapeutic Potential of Human Bone-Marrow-Derived Mesenchymal Stem Cells in Treating Spinal Cord Injury via GDNF. Cell Physiol Biochem. 2017;41(4):1435-1444.[33] 王振宇,刘文革,黄朱宋. bFGF基因修饰骨髓间充质干细胞移植对急性脊髓损伤大鼠神经元的影响[J]. 福建医药杂志, 2010, 32(6):8-10.[34] Lee SH, Kim Y, Rhew D, et al. Impact of local injection of brain-derived neurotrophic factor-expressing mesenchymal stromal cells (MSCs) combined with intravenous MSC delivery in a canine model of chronic spinal cord injury. Cytotherapy. 2016 Oct 28. [Epub ahead of print][35] Lu Y, Gao H, Zhang M, et al. Glial Cell Line-Derived Neurotrophic Factor-Transfected Placenta-Derived Versus Bone Marrow-Derived Mesenchymal Cells for Treating Spinal Cord Injury. Med Sci Monit. 2017;23:1800-1811.[36] 代楠. miR-9、miR-124通过靶向PTBP1促进人脐带间充质干细胞成神经转分化的机制研究[D]. 苏州:苏州大学, 2017.[37] 孙孟坊,王丰,金孟浩, 等. miR-124修饰的骨髓间充质干细胞对大鼠脊髓损伤的作用研究[J]. 全科医学临床与教育, 2017, 15(4):372-375.[38] Zhao Y, Jiang H, Liu XW, et al. MiR-124 promotes bone marrow mesenchymal stem cells differentiation into neurogenic cells for accelerating recovery in the spinal cord injury. Tissue Cell. 2015; 47(2):140-146.[39] 朱奇. 慢病毒介导GAP-43基因修饰骨髓间充质干细胞移植治疗大鼠视神经损伤的实验研究[D]. 长春:吉林大学, 2014.[40] Pu Y, Meng K, Gu C, et al. Thrombospondin-1 modified bone marrow mesenchymal stem cells (BMSCs) promote neurite outgrowth and functional recovery in rats with spinal cord injury. Oncotarget. 2017;8(56):96276-96289.[41] Park YM, Han SH, Seo SK, et al. Restorative benefits of transplanting human mesenchymal stromal cells overexpressing arginine decarboxylase genes after spinal cord injury. Cytotherapy. 2015;17(1):25-37.[42] Stewart AN, Kendziorski G, Deak ZM, et al. Co-transplantation of mesenchymal and neural stem cells and overexpressing stromal-derived factor-1 for treating spinal cord injury. Brain Res. 2017;1672:91-105.[43] Yousefifard M, Nasirinezhad F, Shardi Manaheji H, et al. Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model. Stem Cell Res Ther. 2016;7:36.[44] Oraee-Yazdani S, Hafizi M, Atashi A, et al. Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome. Spinal Cord. 2016;54(2):102-109.[45] Wu S, Cui G, Shao H, et al. The Cotransplantation of Olfactory Ensheathing Cells with Bone Marrow Mesenchymal Stem Cells Exerts Antiapoptotic Effects in Adult Rats after Spinal Cord Injury. Stem Cells Int. 2015;2015:516215.[46] Lindsay SL, Toft A, Griffin J, et al. Human olfactory mesenchymal stromal cell transplants promote remyelination and earlier improvement in gait co-ordination after spinal cord injury. Glia. 2017;65(4):639-656.[47] Nicola FDC, Marques MR, Odorcyk F, et al. Neuroprotector effect of stem cells from human exfoliated deciduous teeth transplanted after traumatic spinal cord injury involves inhibition of early neuronal apoptosis. Brain Res. 2017;1663:95-105.[48] Yang W, Yang Y, Yang JY, et al. Treatment with bone marrow mesenchymal stem cells combined with plumbagin alleviates spinal cord injury by affecting oxidative stress, inflammation, apoptotis and the activation of the Nrf2 pathway. Int J Mol Med. 2016;37(4):1075-1082.[49] Lee SH, Kim Y, Rhew D, et al. Effect of the combination of mesenchymal stromal cells and chondroitinase ABC on chronic spinal cord injury. Cytotherapy. 2015;17(10):1374-1383.[50] Chen D, Zeng W, Fu Y, et al. Bone marrow mesenchymal stem cells combined with minocycline improve spinal cord injury in a rat model. Int J Clin Exp Pathol. 2015;8(10):11957-11969.[51] Rahimi A, Amiri I, Roushandeh AM, et al. Sublethal concentration of H2O2 enhances the protective effect of mesenchymal stem cells in rat model of spinal cord injury. Biotechnol Lett. 2018; 40(3):609-615.[52] Tan JW, Wang KY, Liao GJ, et al. Neuroprotective effect of methylprednisolone combined with placenta-derived mesenchymal stem cell in rabbit model of spinal cord injury. Int J Clin Exp Pathol. 2015;8(8):8976-8982.[53] Yang XM, Cheng YY, Zhang ZL, et al. Role of Methylprednisolone in Treatment of Spinal Cord Injured with Bone Marrow Mesenchymal Stem Cells Transplantation in Rats and Its Effect on the Expressions of Tumor Necrosis Factor-α and Interleukin-1β. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017;39(5):615-622.[54] Libro R, Bramanti P, Mazzon E. The combined strategy of mesenchymal stem cells and tissue-engineered scaffolds for spinal cord injury regeneration. Exp Ther Med. 2017;14(4): 3355-3368.[55] 徐志华,余勤,白月双,等. 补阳还五汤联合鞘内注射间充质干细胞治疗脊髓损伤的研究[J]. 中华中医药学刊,2012,30(12):2726-2729.[56] 吕华兵,牛伟,卜志勇,等. 红花黄素对骨髓间充质干细胞移植修复大鼠脊髓损伤的影响[J]. 湖北医药学院学报,2011,30(3):243-247.[57] 吴晓明,高文山,王静,等. 盐酸川芎嗪联合骨髓间充质干细胞移植对脊髓损伤模型大鼠的神经保护[J]. 中国组织工程研究, 2016, 20(1): 95-101.[58] 何珏,王天科. 丙泊酚联合骨髓间充质干细胞移植对脊髓损伤大鼠后肢功能及电生理的影响[J]. 中国组织工程研究, 2015, 19(41): 6659-6664.[59] 哈小琴,邓芝云,肖娜娜,等. 红景天联合KGF/HIF-1修饰的骨髓间充质干细胞对低氧条件下大鼠脊髓损伤修复的影响[J]. 解放军医药杂志,2015,27(10):15-19.[60] 杨迎桂,郭文家,买志福,等. 角质生长因子、缺氧诱导因子修饰的骨髓间充质干细胞对大鼠脊髓损伤修复的影响[J]. 解放军医药杂志, 2015, 27(10):20-24.[61] 何珏,王天科. 丙泊酚联合骨髓间充质干细胞移植对脊髓损伤大鼠后肢功能及电生理的影响[J]. 中国组织工程研究, 2015, 19(41): 6659-6664.[62] 张建军,王东,刘泽朋,等. 法舒地尔与骨髓间充质干细胞移植治疗大鼠脊髓损伤:有协同效应吗[J]. 中国组织工程研究, 2009, 13(45): 8901-8905.[63] 张振梁,杨新明,孟宪勇,等. 丙戊酸联合骨髓间充质干细胞移植对大鼠脊髓损伤的影响[J]. 中国临床药理学杂志, 2017, 33(8):714-717.[64] 张建军,梁辉,盛学东,等. 他克莫司对骨髓间充质干细胞移植治疗大鼠脊髓损伤的影响[J]. 国际神经病学神经外科学杂志, 2008, 35(5): 398-402.[65] 张占修,李志远,申勇. 乌司他丁联合脐带间充质干细胞移植脊髓损伤大鼠后肢运动功能和运动诱发电位的变化[J].中国组织工程研究, 2012,16(27):5076-5080.[66] Derakhshanrad N, Saberi H, Tayebi Meybodi K, et al. Case Report: Combination Therapy with Mesenchymal Stem Cells and Granulocyte-Colony Stimulating Factor in a Case of Spinal Cord Injury. Basic Clin Neurosci. 2015;6(4):299-305.[67] Peng Z, Gao W, Yue B, et al. Promotion of neurological recovery in rat spinal cord injury by mesenchymal stem cells loaded on nerve-guided collagen scaffold through increasing alternatively activated macrophage polarization. J Tissue Eng Regen Med. 2018;12(3):e1725-e1736.[68] Li LM, Han M, Jiang XC, et al. Peptide-Tethered Hydrogel Scaffold Promotes Recovery from Spinal Cord Transection via Synergism with Mesenchymal Stem Cells. ACS Appl Mater Interfaces. 2017;9(4):3330-3342.[69] Zhao Y, Tang F, Xiao Z, et al. Clinical Study of NeuroRegen Scaffold Combined With Human Mesenchymal Stem Cells for the Repair of Chronic Complete Spinal Cord Injury. Cell Transplant. 2017;26(5):891-900.[70] Wang N, Xiao Z, Zhao Y, et al. Collagen scaffold combined with human umbilical cord-derived mesenchymal stem cells promote functional recovery after scar resection in rats with chronic spinal cord injury. J Tissue Eng Regen Med. 2018;12(2):e1154-e1163.[71] Mortazavi Y, Sheikhsaran F, Khamisipour GK, et al. The Evaluation of Nerve Growth Factor Over Expression on Neural Lineage Specific Genes in Human Mesenchymal Stem Cells. Cell J. 2016;18(2):189-196. |